Syndax Pharmaceuticals Inc (SNDX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

35 GATEHOUSE DRIVE WALTHAM, MA 02451

Syndax Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company offers therapies to treat solid tumors and lung, breast, and hematological cancer. Syndax Pharmaceuticals serves the medical and healthcare sectors in the United States.

Data as of 2021-04-17 10:47:35 -0400
Market Cap984.492 Million Shares Outstanding48.236 Million Avg 30-day Volume757.631 Thousand
P/E Ratio-12.77499 Dividend Yield0.0 EPS-1.87
Price/Sales704.62 Debt to Equity1.19 EBITDA-71.334 Million
Price to Book Value4.24 Forward PE-10.09 Enterprise Value791.275 Million
Total Cash297.748 Million Current Debt18.872 Million Gross Profit1.517 Million
BETA0.80793 52-week High/Low27.85 / 10.2 Next Earnings Date2021-05-06 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from SNDX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 2 150.0% 4 (0.24%) 2 (0.12%) 100.0%
Funds Holding: 141 99 42.42% 65 (3.91%) 48 (2.99%) 35.42%
13F shares: 46.456 Million 34.234 Million 35.7% 31.557 Million 24.352 Million 29.59%
% Ownership 98.4556 83.7655 17.54% 66.8791 59.5851 12.24%
New Positions: 53 16 231.25% 20 10 100.0%
Increased Positions 50 28 78.57% 27 14 92.86%
Closed Positions 10 14 -28.57% 3 5 -40.0%
Reduced Positions 24 36 -33.33% 15 15 0.0%
Total Calls 380.508 Thousand 75.802 Thousand 401.98% 133.404 Thousand 30.9 Thousand 331.73%
Total Puts 155.312 Thousand 100.2 Thousand 55.0% 62.1 Thousand 31.9 Thousand 94.67%
PUT/CALL Ratio 0.41 1.32 -68.94% 0.47 1.03 -54.37%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SNDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SNDX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

10.2 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

10.2 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EGROS FABRICE

16,000 2021-03-01 2

MORRISON BRIGGS CHIEF EXECUTIVE OFFICER

48,336 2021-02-08 3

MEYERS MICHAEL L. SVP, CHIEF MEDICAL OFFICER

15,166 2021-02-03 2

PODLESAK DENNIS

29,333 2021-02-03 1

ORDENTLICH PETER CHIEF SCIENTIFIC OFFICER

0 2021-02-03 2

METZGER MICHAEL A PRESIDENT AND COO

0 2021-02-03 4

LEGAULT PIERRE

16,000 2021-02-03 1

KATKIN KEITH

16,000 2021-02-03 1

JARRETT JENNIFER

16,000 2021-02-03 1

MEURY WILLIAM

16,000 2021-02-03 1

KARYDAS DAPHNE CHIEF FINANCIAL OFFICER

0 2021-02-03 2

SHEA RICHARD P CHIEF FINANCIAL OFFICER

7,121 2020-02-12 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
No longer subject to file 2018-06-18 0

EVNIN LUKE

0 2018-05-23 0

CHEN HENRY

0 2018-05-23 0

SLEDGE GEORGE W. JR.

0 2017-05-17 0

ROYSTON IVOR

625,545 2017-03-20 0

KAMDAR KIM P.

  • Director
  • 10% Owner
0 2016-10-31 0

MPM BIOVENTURES IV QP LP

SCOPA JAMES PAUL

FOLEY TODD

GADICKE ANSBERT

KAILIAN VAUGHN M

MPM ASSET MANAGEMENT INVESTORS BV4 LLC

MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

MPM BIOVENTURES IV GP LLC

MPM BIOVENTURES IV LLC

MPM BIOVENTURES IV STRATEGIC FUND, L.P.

  • 10% Owner
2,168,691 2016-03-08 0

DP VIII ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
5,641 2016-03-08 0

DOMAIN PARTNERS VIII, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
761,062 2016-03-08 0

DOMAIN PARTNERS VI, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

  • 10% Owner
1,743,854 2016-03-08 0

DP VI ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

  • Director
  • 10% Owner
13,925 2016-03-08 0

SHAW ALLAN CHIEF FINANCIAL OFFICER

  • Officer
0 2016-03-02 0

DOMAIN ASSOCIATES

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

KAMDAR KIM P.

SHAH NIMESH

  • Director
  • 10% Owner
13,564 2016-03-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

EGROS FABRICE

2021-03-03 16:16:46 -0500 2021-03-01 M 10,167 $6.35 a 26,167 direct 4.4287 3.2329 -9.6103 11.5146 22 -9.6103 31

EGROS FABRICE

2021-03-03 16:16:46 -0500 2021-03-01 M 10,167 d 0 direct

EGROS FABRICE

2021-03-03 16:16:46 -0500 2021-03-01 S 10,167 $24.31 d 16,074 direct yes 4.4287 3.2329 -9.6103 11.5146 22 -9.6103 31

EGROS FABRICE

2021-03-03 16:16:46 -0500 2021-03-01 M 74 d 0 direct

EGROS FABRICE

2021-03-03 16:16:46 -0500 2021-03-01 M 74 $7.20 a 26,241 direct 4.4287 3.2329 -9.6103 11.5146 22 -9.6103 31

EGROS FABRICE

2021-03-03 16:16:46 -0500 2021-03-01 S 74 $24.31 d 16,000 direct yes 4.4287 3.2329 -9.6103 11.5146 22 -9.6103 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 22:15:03 UTC -0.2452 0.3052 650000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 21:45:03 UTC -0.2452 0.3052 650000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 21:15:02 UTC -0.2452 0.3052 650000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 20:45:03 UTC -0.2404 0.3004 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 20:15:04 UTC -0.2404 0.3004 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 19:45:03 UTC -0.2404 0.3004 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 19:15:03 UTC -0.2404 0.3004 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 18:45:03 UTC -0.24 0.3 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 18:15:03 UTC -0.24 0.3 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 17:45:02 UTC -0.24 0.3 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 17:15:02 UTC -0.24 0.3 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 16:45:03 UTC -0.2018 0.2618 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 16:15:03 UTC -0.2018 0.2618 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 15:45:03 UTC -0.2018 0.2618 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 15:15:02 UTC -0.2018 0.2618 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 14:45:03 UTC -0.235 0.295 600000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 14:15:03 UTC -0.235 0.295 650000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 13:45:03 UTC -0.235 0.295 650000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 13:15:04 UTC -0.235 0.295 650000
SYNDAX PHARMACEUTICALS INC SNDX 2021-04-20 12:45:03 UTC -0.235 0.295 650000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments